Calcium phytate reverses high glucose‐inhibited osteogenesis of BMSCs via the MAPK / JNK pathway
Oral Diseases · 2024
DOI: 10.1111/odi.14598 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2024. Verfasst von Jiaxin Lv und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dental Implantology, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Cell Differentiation, Glucose, MAP Kinase Signaling System, Mesenchymal Stem Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: International Science and Technology Cooperation Program of China, National Natural Science Foundation of China, National Science Fund for Distinguished Young Scholars.
Abstract (Originalsprache)
Objectives
Diabetes mellitus (DM) induces oxidative tissue impairment and suppresses bone formation. Some studies have shown that phytic acid has antioxidant and anti‐diabetic properties. This study aimed to investigate the potential of calcium phytate (Ca‐phytate) to reverse inhibited osteogenesis of human bone marrow mesenchymal stem cells (hBMSCs) in a high glucose (HG) environment and to determine the underlying mechanism. Materials and Methods hBMSCs were exposed to HG and palmitic acid to simulate DM in vitro. Osteogenic differentiation was measured using alkaline phosphatase staining and activity assay, alizarin red S staining, qRT‐PCR, Western blot and immunofluorescence staining. A critical‐size cranial defect model of type 2 diabetes mellitus (T2DM) rats was established to evaluate bone regeneration. A specific pathway inhibitor was used to explore whether the MAPK/JNK pathway was involved.
Results
Treatment with 34 μM Ca‐phytate had the highest effect on osteogenic differentiation in HG. Ca‐phytate improved cranial bone defect healing in T2DM rats. The long‐term HG environment inhibited the activation of the MAPK/JNK signalling pathway, which was restored by Ca‐phytate. Blocking the JNK pathway reduced the Ca‐phytate‐mediated osteogenic differentiation of hBMSCs.
Conclusion
Ca‐phytate induced bone regeneration in vivo and reversed HG‐inhibited osteogenesis of hBMSCs in vitro via the MAPK/JNK signalling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dental Implantology, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, China.
- Jiangsu Key Laboratory of Oral Diseases, Jiangsu Province Engineering Research Center of Stomatological Translational Medicine, Nanjing, China.
- Department of Oral Special Consultation, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, China.
- Department of Orthodontic, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, China.
ORCID-Profile: Chunbo Tang
Förderung
- International Science and Technology Cooperation Program of China
- National Natural Science Foundation of China
- National Science Fund for Distinguished Young Scholars
- Southeast University and Nanjing Medical University Cooperative Research Project
- The Jiangsu Province Capability Improvement Project through Science, Technology and Education-Jiangsu Provincial Research Hospital Cultivation Unit
- Jiangsu Provincial Medical Innovation Center
Zitieren
APA
Lv, J., Wang, Q., Liu, D., Chu, C. H., Zhou, H., Li, G., Wu, J., Cai, K., & Tang, C. (2024). Calcium phytate reverses high glucose‐inhibited osteogenesis of BMSCs via the MAPK / JNK pathway. Oral Diseases. https://doi.org/10.1111/odi.14598
Vancouver
Lv J, Wang Q, Liu D, Chu CH, Zhou H, Li G, et al. Calcium phytate reverses high glucose‐inhibited osteogenesis of BMSCs via the MAPK / JNK pathway. Oral Diseases. 2024. doi:10.1111/odi.14598
BibTeX
@article{Lv2024,
author = {Lv, Jiaxin and Wang, Qiaona and Liu, Dongyu and Chu, Catherine Huihan and Zhou, Heyang and Li, Guoqing and Wu, Jin and Cai, Kunzhan and Tang, Chunbo},
title = {Calcium phytate reverses high glucose‐inhibited osteogenesis of BMSCs via the MAPK / JNK pathway},
journal = {Oral Diseases},
year = {2024},
doi = {10.1111/odi.14598}
}
EUVIMED